Stay updated on Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial
Sign up to get notified when there's something new on the Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial page.

Latest updates to the Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a new release. The removal of the 'Back to Top' element is a minor UI change and does not affect core content.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to drug safety and various pharmaceutical preparations. Notably, several terms related to vaccines and specific diseases have been removed.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to include detailed information about a clinical trial evaluating the safety and immunogenicity of a new tetravalent dengue vaccine (V180) in healthy adults. This includes specifics on study design, eligibility criteria, and contact information for potential participants.SummaryDifference100%
Stay in the know with updates to Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial page.